Piergentili, R.; Marinelli, E.; Cucinella, G.; Lopez, A.; Napoletano, G.; Gullo, G.; Zaami, S.
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. Non-Coding RNA 2024, 10, 16.
https://doi.org/10.3390/ncrna10020016
AMA Style
Piergentili R, Marinelli E, Cucinella G, Lopez A, Napoletano G, Gullo G, Zaami S.
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. Non-Coding RNA. 2024; 10(2):16.
https://doi.org/10.3390/ncrna10020016
Chicago/Turabian Style
Piergentili, Roberto, Enrico Marinelli, Gaspare Cucinella, Alessandra Lopez, Gabriele Napoletano, Giuseppe Gullo, and Simona Zaami.
2024. "miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine" Non-Coding RNA 10, no. 2: 16.
https://doi.org/10.3390/ncrna10020016
APA Style
Piergentili, R., Marinelli, E., Cucinella, G., Lopez, A., Napoletano, G., Gullo, G., & Zaami, S.
(2024). miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. Non-Coding RNA, 10(2), 16.
https://doi.org/10.3390/ncrna10020016